drugset / Trial / NCT05759208
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to compare the safety and efficacy of OK-101 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Timeline
- Start
- 2023-04-28
- Primary completion
- 2023-12-15
- Completion
- 2023-12-15
Outcome
Missed primary endpoint
release “While we didn’t meet the original primary endpoints, the totality of the data support advancing forward with a new study design” okyopharma.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OK-101 | Peptide | 0.05 % | Other |
| Subject | OK-101 | Peptide | 0.1 % | Other |